There hasnt been a phase 3 trial specifically combining a GLP-1 with phentermine designed to seek FDA approval
To answer that question, McDonald and her colleagues are working to launch a multisite clinical trial examining whether GLP-1 medications can lower breast cancer incidence in women considered high risk, including some with a previous history of breast cancer
However, the science remains incomplete
A few important points: Quality matters significantly: Medically dispensed peptides come from verified pharmacies, which avoids the purity, dosing inconsistencies, and fillers sometimes found in over-the-counter or research-use products
While these treatments remain in various stages of development, they highlight the growing recognition that novel, mechanism-driven therapies are needed to address addiction effectively
Follow the prescribing guidance from your doctor